John J. Alam - 14 Jun 2024 Form 4 Insider Report for CervoMed Inc. (CRVO)

Role: CEO & President, Director, 10%+ Owner
Signature: /s/ William R. Elder, attorney-in-fact for the Reporting Person
Issuer symbol: CRVO
Transactions as of: 14 Jun 2024
Net transactions value: $0
Form type: 4
Filing time: 14 Jun 2024, 18:28:19 UTC
Previous filing: 26 Jan 2024
Next filing: 14 Feb 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRVO	Stock Option (Right to Buy)	Award	$0	+5,750		$0.000000	5,750	14 Jun 2024	Common Stock	5,750	$19.01	By Spouse	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of an option to purchase shares of common stock granted to Sylvie Gregoire, PharmD., the Reporting Person's spouse and a non-employee director of the Issuer. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F2	The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2024, subject to the Dr. Gregoire's continued service through the applicable vesting date.

Content

Consists of an option to purchase shares of common stock granted to Sylvie Gregoire, PharmD., the Reporting Person's spouse and a non-employee director of the Issuer. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2024, subject to the Dr. Gregoire's continued service through the applicable vesting date.